Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Iovance Biotherapeutics (IOVA) over the last 10 years, with Q3 2025 value amounting to 0.53%.

  • Iovance Biotherapeutics' Return on Capital Employed changed N/A to 0.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.53%, marking a year-over-year change of. This contributed to the annual value of 0.55% for FY2024, which is N/A changed from last year.
  • Per Iovance Biotherapeutics' latest filing, its Return on Capital Employed stood at 0.53% for Q3 2025.
  • Iovance Biotherapeutics' 5-year Return on Capital Employed high stood at 0.42% for Q2 2023, and its period low was 0.65% during Q4 2023.
  • For the 3-year period, Iovance Biotherapeutics' Return on Capital Employed averaged around 0.52%, with its median value being 0.52% (2025).
  • Its Return on Capital Employed has fluctuated over the past 5 years, first tumbled by -2100bps in 2024, then surged by 1400bps in 2025.
  • Iovance Biotherapeutics' Return on Capital Employed (Quarter) stood at 0.65% in 2023, then rose by 3bps to 0.63% in 2024, then increased by 15bps to 0.53% in 2025.
  • Its Return on Capital Employed stands at 0.53% for Q3 2025, versus 0.51% for Q2 2025 and 0.49% for Q1 2025.